<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>400</number>
    <updateDate>2022-11-01T15:47:44Z</updateDate>
    <updateDateIncludingText>2022-11-01T15:47:44Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2019-02-07</introducedDate>
    <congress>116</congress>
    <committees>
      <item>
        <systemCode>ssfr00</systemCode>
        <name>Foreign Relations Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2019-02-07T20:41:56Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Blocking Deadly Fentanyl Imports Act</title>
        <congress>116</congress>
        <number>1098</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-02-07</actionDate>
          <text>Referred to the House Committee on Foreign Affairs.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2019-02-07</actionDate>
        <committees>
          <item>
            <systemCode>ssfr00</systemCode>
            <name>Foreign Relations Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Foreign Relations.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2019-02-07</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>T000461</bioguideId>
        <fullName>Sen. Toomey, Patrick [R-PA]</fullName>
        <firstName>Patrick</firstName>
        <lastName>Toomey</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>J.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>J000300</bioguideId>
        <fullName>Sen. Jones, Doug [D-AL]</fullName>
        <firstName>Doug</firstName>
        <lastName>Jones</lastName>
        <party>D</party>
        <state>AL</state>
        <sponsorshipDate>2019-02-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001070</bioguideId>
        <fullName>Sen. Casey, Robert P., Jr. [D-PA]</fullName>
        <firstName>Bob</firstName>
        <lastName>Casey</lastName>
        <party>D</party>
        <state>PA</state>
        <sponsorshipDate>2019-03-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001047</bioguideId>
        <fullName>Sen. Capito, Shelley Moore [R-WV]</fullName>
        <firstName>Shelley</firstName>
        <lastName>Capito</lastName>
        <party>R</party>
        <state>WV</state>
        <middleName>Moore</middleName>
        <sponsorshipDate>2019-05-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001056</bioguideId>
        <fullName>Sen. Cornyn, John [R-TX]</fullName>
        <firstName>John</firstName>
        <lastName>Cornyn</lastName>
        <party>R</party>
        <state>TX</state>
        <sponsorshipDate>2019-12-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000293</bioguideId>
        <fullName>Sen. Johnson, Ron [R-WI]</fullName>
        <firstName>Ron</firstName>
        <lastName>Johnson</lastName>
        <party>R</party>
        <state>WI</state>
        <sponsorshipDate>2020-01-14</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000595</bioguideId>
        <fullName>Sen. Rubio, Marco [R-FL]</fullName>
        <firstName>Marco</firstName>
        <lastName>Rubio</lastName>
        <party>R</party>
        <state>FL</state>
        <sponsorshipDate>2020-01-14</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>International Affairs</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Criminal investigation, prosecution, interrogation</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Foreign aid and international relief</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Trade restrictions</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>International Affairs</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2019-02-07</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2019-09-30T15:26:05Z</updateDate>
        <text><![CDATA[ <p><b>Blocking Deadly Fentanyl Imports Act</b></p> <p>This bill expands reporting requirements related to foreign countries that produce illicit fentanyl and limits assistance to countries that fail to take various actions to combat illegal drug production and trafficking.</p> <p>The President's annual report to Congress on U.S. strategy for controlling international narcotics shall include a section that identifies the countries that are the most significant sources of illicit fentanyl, fentanyl analogues, and precursor chemicals used for producing fentanyl. The report shall also describe the extent to which&nbsp;such a country has cooperated with U.S. efforts to prevent exports of such substances into the United States.</p> <p>The United States shall withhold 50% of the foreign assistance allocated to each identified country for the fiscal year. The Department of the Treasury shall also direct U.S. Executive Directors in each multilateral development bank to vote against making loans or allocating funds to such countries. Both restrictions may be waived if the President certifies that the country has cooperated fully with U.S. anti-drug trafficking efforts or if vital U.S. national interests necessitate&nbsp;such a waiver.</p> <p>The bill also directs the President to identify countries that (1) have not adopted various procedures for countering narcotics production and distribution, or (2)&nbsp;are incapable of prosecuting individuals that manufacture or distribute new types of drugs. <br /></p>]]></text>
      </summary>
    </summaries>
    <title>Blocking Deadly Fentanyl Imports Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Blocking Deadly Fentanyl Imports Act</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Blocking Deadly Fentanyl Imports Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to gather information about the illicit production of illicit fentanyl in foreign countries and to withhold bilateral assistance from countries that do not have emergency scheduling procedures for new illicit drugs, cannot prosecute criminals for the manufacture or distribution of controlled substance analogues, or do not require the registration of tableting machine and encapsulating machines.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2019-02-07T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s400is/xml/BILLS-116s400is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2019-02-07</actionDate>
      <text>Read twice and referred to the Committee on Foreign Relations.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
